Glaucoma Surgery Market Size, Share & Forecast, 2023-2032 |...

Glaucoma Surgery Market Size, Share & Forecast, 2023-2032

Posted 2024-02-16 12:19:45

Market Overview –

The Glaucoma Surgery market encompasses surgical interventions aimed at managing glaucoma, a leading cause of irreversible blindness worldwide. Glaucoma surgery is indicated when other treatment modalities such as medication and laser therapy fail to adequately control intraocular pressure (IOP). Surgical procedures like trabeculectomy, minimally invasive glaucoma surgery (MIGS), and implantation of drainage devices are among the common approaches employed to reduce IOP and prevent optic nerve damage. With the aging population and the increasing incidence of glaucoma, particularly in developing regions, the demand for glaucoma surgery is expected to rise. Technological advancements leading to safer and more effective surgical techniques, along with favorable reimbursement policies for glaucoma procedures, are driving market growth. Moreover, the growing awareness about the importance of early detection and treatment of glaucoma further fuels market expansion. However, challenges such as the high cost of surgical procedures and the risk of complications associated with surgery may hinder market growth in some regions.

The Glaucoma Surgery Market, also referred to as surgical glaucoma, is witnessing significant growth due to the rising prevalence of glaucoma and advancements in surgical techniques. Surgical interventions such as trabeculectomy and minimally invasive glaucoma surgery (MIGS) are increasingly preferred options for managing the condition, driving market expansion.

The Glaucoma Surgery Market Size was assessed at USD 0.6 billion in 2022 and is expected to rise from USD 0.63 billion in 2023 to USD 1.3 billion by 2032, with a compound annual growth rate (CAGR) of 6.7% during the forecast period (2023-2032).

Market Segmentation –

The glaucoma surgery market is segmented by target, operation type, geography, and end user. The glaucoma surgery market is categorized by target, including suprachoroidal space, trabecular meshwork, and others. The global glaucoma surgery market is divided into five regions: Asia Pacific, the Middle East, North America, Europe, and Africa. The glaucoma surgery market is divided into four types: aqueous shunt surgery, laser surgery, angle-closure glaucoma surgery, and other procedures. The glaucoma surgery market is categorized by end-users, including ambulatory surgery centers, hospitals, and others.

Regional Analysis –

The regional analysis of the Glaucoma Surgery market indicates varying trends across different regions globally. North America holds a significant share in the market due to factors such as a high prevalence of glaucoma, advanced healthcare infrastructure, and favorable reimbursement policies. Additionally, the presence of key market players and ongoing research and development activities contribute to market dominance. In Europe, the market is also prominent, driven by increasing awareness about eye health, aging populations, and advancements in surgical techniques. The Asia-Pacific region shows significant growth potential attributed to rising healthcare expenditure, increasing geriatric population, and improving access to healthcare facilities. Emerging markets in Latin America and Africa are witnessing gradual market expansion as healthcare infrastructure improves and awareness about glaucoma treatment options increases. However, challenges such as limited access to specialized healthcare services and affordability issues may hinder market growth in these regions.

Key Players –

Glaucoma Surgery companies include Abbott Laboratories Inc, Carl Zeiss Meditec, Ziemer Ophthalmic Systems, ASICO, LLC, Lumenis, Allergan, Alcon, Katalyst Surgical LLC, Glaukos Corporation, among others.